Effect of formulation factors on incorporation of the hydrophilic peptide dalargin into PLGA and mPEG-PLGA nanoparticles

Biopolymers - Peptide Science Section

Volumn 90, Issue 5, 2008, Pages 644-650

  Chen, Y ^a   Wang, F ^a   Benson, Heather A E ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Dalargin; Ionic additives; mPEG PLGA; Nanoparticles; Peptide delivery; PLGA

Indexed keywords

DALARGIN; IONIC ADDITIVES; MPEG-PLGA; PEPTIDE DELIVERY; PLGA;

AMINES; CATALYST ACTIVITY; DIELECTRIC RELAXATION; DIFFUSERS (OPTICAL); ETHERS; ETHYLENE GLYCOL; EVAPORATION; GLUCOSE; HYDROPHILICITY; MICELLES; MOTION PICTURE EXPERTS GROUP STANDARDS; PARTICLE SIZE; PEPTIDES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; POLYMER SOLUTIONS; POLYMERS; SODIUM; SODIUM SULFATE; SOLVENTS; SURFACE ACTIVE AGENTS; VAPORS;

NANOPARTICLES;

DRUG DERIVATIVE; ENKEPHALIN LEU, ALA(2) ARG(6); ENKEPHALIN-LEU, ALA(2)-ARG(6)-; ENKEPHALIN[2 ALANINE 5 LEUCINE]; LACTIC ACID; MACROGOL DERIVATIVE; MONOMETHOXYPOLYETHYLENE GLYCOL; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; UNCLASSIFIED DRUG;

ARTICLE; CHEMISTRY; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; METABOLISM;

DRUG DELIVERY SYSTEMS; ENKEPHALIN, LEUCINE-2-ALANINE; LACTIC ACID; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID;

EID: 58149185967     PISSN: 00063525     EISSN: 10970282     Source Type: Journal    
DOI: 10.1002/bip.21013     Document Type: Conference Paper

References (19)

1. Avgoustakis, K.; Beletsi, A.; Panagi, Z.; Klepetsanis, P.; Livaniou, E.; Evangelatos, G.; Ithakissios, D. S. Int J Pharm 2003, 259, 115-127.
2. Li, Y.-P.; Pei, Y.-Y.; Zhang, X.-Y.; Gu, Z.-H.; Zhou, Z.-H.; Yuan, W.-F.; Zhou, J.-J.; Zhu, J.-H.; Gao, X.-J. J Control Release 2001, 71, 203-211.
3. Yadav, A. K.; Mishra, P.; Mishra, A. K.; Mishra, P.; Jain, S.; Agrawal, G. P. Nanomedicine 2007, 3, 246-257.
4. Olivier, J. C.; Huertas, R.; Lee, H. J.; Calon, F.; Pardridge, W. M. Pharm Res 2002, 19, 1137-1143.
5. Olivier, J. C. NeuroRx 2005, 2, 108-119.
6. Govender, T.; Riley, T.; Ehtezazi, T.; Garnett, M. C.; Stolnik, S.; Illum, L.; Davis, S. S. Int J Pharm 2000, 199, 95-110.
7. Cui, F.; Shi, K.; Zhang, L.; Tao, A.; Kawashima, Y. J Control Release 2006, 114, 242-250.
8. Ranney, D.; Antich, P.; Dadey, E.; Mason, R.; Kulkarni, P.; Singh, O.; Chen, H.; Constantanescu, A.; Parkey, R. J Control Release 2005, 109, 222-235.
9. Chen, Y.; Mohanraj, V.; Parkin, J. Int J Pept Res Ther 2003, 10, 621-629.
10. Chen, Y.; Mohanraj, V. J.; Wang, F.; Benson, H. A. E. In AAPS PharmSciTech, 2007, p Article 98.
11. Chen, Y.; McCulloch, R. K.; Gray, B. N. J Control Release 1994, 31, 49-54.
12. Belesti, A.; Leontiadis, L.; Klepetsains, P. Int J Pharm 1999, 182, 187-197.
13. Dong, Y.; Feng, S. S. Biomaterials 2004, 25, 2843-2849.
14. Avgoustakis, K.; Beletsi, A.; Panagi, Z.; Klepetsanis, P.; Karydas, A. G.; Ithakissios, D. S. J Control Release 2002, 79, 123-135.
15. Minko, T. In Martin's Physical Pharmacy and Pharmaceutical Sciences; Sinko, P., Ed.; Lippincott Williams & Wilkins: Philadephia, 2006, pp 469-498.
16. Chen, Y.; Yoo, O. H.; Benson, H. A. E. Innovation in drug delivery: from biomaterials to devices, Naples, Italy, Sept 30-Oct 3, 2007, p 235.
17. Murakami, H.; Kobayashi, M.; Takeuchi, H.; Kawashima, Y. Int J Pharm 1999, 187, 143-152.
18. Wang, Y.; Ng, Y. W.; Chen, Y.; Shuter, B.; Yi, J.; Ding, J.; Wang, S. C.; Feng, S. S. Adv Funct Mater 2008, 18, 308-318.
19. Olivier, J. C.; Fenart, L.; Chauvet, R.; Pariat, C.; Cecchelli, R.; Couet, W. Pharm Res 1999, 16, 1836-1842.